ArticleBMC endocrine disorders2022

Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study.

Ming-Ming Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.